Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Kai Chan

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2024
A new immune pathway mediating AAV immune responsesYing Kai Chan
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 26, 2024
Gene therapy trial lights the way for patients with Leber congenital amaurosis 1Ying Kai Chan
Molecular Therapy. Advances|May 15, 2026
Deciphering the role and contribution of AAV immune responses to DRG toxicityJuliette Hordeaux, Ying Kai Chan
Cell Host & Microbe|March 14, 2015
RIG-I works double dutyYing Kai Chan, Michaela U Gack
Nature Immunology|March 22, 2016
A phosphomimetic-based mechanism of dengue virus to antagonize innate immunityYing Kai Chan, Michaela U Gack
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 16, 2023
Analyzing clinical observations to better understand and manage immune responses to AAV gene therapiesYing Kai Chan, Terence R Flotte
Current Opinion in Virology|February 4, 2015
RIG-I-like receptor regulation in virus infection and immunityYing Kai Chan, Michaela U Gack
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2021
Does systemic inflammation prompt gene therapy uveitis?Ying Kai Chan, Kathryn L Pepple
Nature Reviews. Microbiology|May 14, 2016
Viral evasion of intracellular DNA and RNA sensingYing Kai Chan, Michaela U Gack
Plos One|April 6, 2012
IFITM proteins restrict antibody-dependent enhancement of dengue virus infectionYing Kai Chan, I-Chueh Huang, Michael Farzan
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2024
A new immune pathway mediating AAV immune responsesYing Kai Chan
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 26, 2024
Gene therapy trial lights the way for patients with Leber congenital amaurosis 1Ying Kai Chan
Molecular Therapy. Advances|May 15, 2026
Deciphering the role and contribution of AAV immune responses to DRG toxicityJuliette Hordeaux, Ying Kai Chan
Cell Host & Microbe|March 14, 2015
RIG-I works double dutyYing Kai Chan, Michaela U Gack
Nature Immunology|March 22, 2016
A phosphomimetic-based mechanism of dengue virus to antagonize innate immunityYing Kai Chan, Michaela U Gack
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 16, 2023
Analyzing clinical observations to better understand and manage immune responses to AAV gene therapiesYing Kai Chan, Terence R Flotte
Current Opinion in Virology|February 4, 2015
RIG-I-like receptor regulation in virus infection and immunityYing Kai Chan, Michaela U Gack
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2021
Does systemic inflammation prompt gene therapy uveitis?Ying Kai Chan, Kathryn L Pepple
Nature Reviews. Microbiology|May 14, 2016
Viral evasion of intracellular DNA and RNA sensingYing Kai Chan, Michaela U Gack
Plos One|April 6, 2012
IFITM proteins restrict antibody-dependent enhancement of dengue virus infectionYing Kai Chan, I-Chueh Huang, Michael Farzan
Pageof 4